Ashley Van Zeeland (Neuroscientist) Wiki, Biography, Age, Husband, Family, Net Worth

Ashley Van Zeeland Wiki,Biography, Net Worth

Ashley Van Zeeland is an American neuroscientist, focusing on genomics, genetics, and biotechnology in the fields of autism and anorexia nervosa. Her work on autism revealed that genetic variants were linked to different communication pathways within the brain, and her work related anorexia nervosa to an enzyme regulating cholesterol metabolism.

Explore Ashley Van Zeeland Wiki Age, Height, Biography as Wikipedia, Husband, Family relation. There is no question Ashley Van Zeeland is the most famous & most loved celebrity of all the time. You can find out how much net worth Ashley Van has this year and how she spent her expenses. Also find out how she got rich at the age of 38. She has a pure loving kind heart personality. Scroll Down and find everything about her.

Ashley Van Zeeland Wiki, Biography

Date of Birth 1982
Birth Day 10 December
Birth Years 1982
Age 38 years old
Birth Place University of Colorado Boulder, UCLA, University of California, San Diego
Birth City University of California
Birth Country United States of America
Nationality American
Famous As Neuroscientist
Also Known for Neuroscientist
Zodiac Sign Cancer
Occupation Neuroscientist

Famously known by the Family name Ashley Van Zeeland, is a great Neuroscientist. She was born on 1982, in University of Colorado Boulder, UCLA, University of California, San Diego. University of California is a beautiful and populous city located in University of Colorado Boulder, UCLA, University of California, San Diego United States of America.

Read Also: Ken Burrow Wiki, Biography, Age, Net Worth, Family, Instagram, Twitter, Social Profiles & More Facts

Ashley Van Zeeland Net Worth

Ashley Van Zeeland has a net worth of $5.00 million (Estimated) which she earned from her occupation as Neuroscientist. Popularly known as the Neuroscientist of United States of America. She is seen as one of the most successful Neuroscientist of all times. Ashley Van Zeeland Net Worth & Basic source of earning is being a successful American Neuroscientist.

Ashley Van entered the career as Neuroscientist In her early life after completing her formal education..

Net Worth

Estimated Net Worth in 2022 $1 Million to $5 Million Approx
Previous Year’s Net Worth (2021) Being Updated
Salary in 2021 Not Available
Annual Salary Being Updated
Cars Info Not Available
Income Source Neuroscientist

Ashley Van Zeeland’s official Twitter account

The Neuroscientist with a large number of Twitter followers, with whom she shares her life experiences. Ashley Van is gaining More popularity of her Profession on Twitter these days. You can read today’s latest tweets and post from Ashley Van Zeeland’s official Twitter account below, where you can know what she is saying in her previous tweet. Read top and most recent tweets from his Twitter account here…

Social Network

Born on 1982, the Neuroscientist Ashley Van Zeeland is arguably the world’s most influential social media star. Ashley Van is an ideal celebrity influencer. With her large number of social media fans, she often posts many personal photos and videos to interact with her huge fan base on social media platforms. Personal touch and engage with her followers. You can scroll down for information about her Social media profiles.

Social Media Profiles and Accounts

Twitter Ashley Van Zeeland Official Twitter
Instagram Not Available
Facebook Not Available
Wikipedia Ashley Van Zeeland Wikipedia
YouTube Not Available
Spotify Not Available
Website Not Available
Itunes Not Available
Pandora Not Available
Googleplay Not Available
Deezer Not Available
Quora Not Available
Soundcloud Not Available

Life Story & Timeline


In 2013, Van Zeeland was named a San Diego Young Influential. The San Diego Young Influential’s Award “highlights young entrepreneurs and successful business leaders who are the next generation of Top Influentials, San Diego County’s young movers and shakers.” In 2012, she was named a PitchFest Finalist by the San Diego Venture Group, meaning that Cypher Genomic’s business pitch beat out hundreds of other contestants from around the country. In 2011, Van Zeeland was a part of the mystartupXX Program when the program received a $50,000 grant from the U.S. Small Business Association. The mission of the mystartupXX Program is “to nurture the next generation of female founder and female-led technology startups through mentorship, education and funding.” In 2010, Van Zeeland won the International Society for Autism Research Neurobiological Dissertation Award for her work discovering genetic variants are linked to different communication pathways within the brain. Van Zeeland also received the honor of being named a Dickinson Fellow in 2009. In 2007, she was the recipient of the Pre-doctoral Ruth L. Kirschstein National Research Service Award which is an award given out by the National Institutes of Health.


She co-founded Cypher Genomics in March 2011 with Eric Topol, Nicholas Schork, and Ali Torkamani in La Jolla, CA. She is the CEO of Cypher Genomics, which is partnering with the Clinic for Special Children in Strasburg, Pennsylvania to diagnose rare genetic diseases among Amish and Mennonite patients, a population with a relatively high incidence of genetic disease.


In addition to co-founding Cypher Genomics, Van Zeeland is also a published author on subjects of both anorexia and autism. As mentioned in the abstract, Van Zeeland’s work with autism showed that there are genetic variants linked in different communication pathways. The study was published in Science Translational Medicine in her 2010 article, “Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2.” The study used a combination of genetics and imaging phenotypes to determine that a lack of connectivity between the frontal lobe may be connected to the genetic variation at CNTNAP2 that predisposes subjects to autism. Van Zeeland was the primary author on a 2013 Anorexia Nervosa study that was completed at The Scripps Translational Science Institute. The study was entitled “Evidence for the role of EPHX2 gene variants in anorexia nervosa” and was published in Molecular Psychiatry. This study looked at 150 different candidate genes in over 1200 Anorexia Nervosa subjects and over 1900 control subjects in order to try to find a genetic difference in subjects with the disease. Through sequencing and genotyping of the candidate genes of the subjects, it was determined that there was evidence that showed a variance in the EPHX2 gene to be linked to Anorexia Nervosa as well as elevated cholesterol levels.


After receiving her PhD, she worked as a consultant on a consortium study to investigate mitochondrial dysfunction in children with autism at the University of California San Diego from 2009 to 2010. She went on to attain her MBA from the University of California, San Diego Rady School of Management in 2012. While at Rady, she began developing the idea for Cypher Genomics through the school’s Lab to Market course series and its business accelerator mystartupXX. From 2009 to 2011, she worked as a distinguished Dickinson Research Fellow at the Scripps Translational Medicine Institute. After receiving her MBA, she served as the Director of Strategic Partnerships at Scripps Genomic Medicine where she managed a portfolio of public-private partnerships for CTSA supported Scripps Translational Science Institute. Currently, Van Zeeland serves as the CEO and co-founder of Cypher Genomics.


Van Zeeland received her BA in psychology from the University of Colorado Boulder in 2002. Afterwards, she worked from 2002 to 2004 as a project coordinator for the Colorado Learning Disabilities Twin Study at the University of Denver. Van Zeeland also worked as a project coordinator for the UCLA Autism Center of Excellence from 2004 to 2005. She then received her PhD in neuroscience from the University of California, Los Angeles in 2009. For her PhD, she worked in the Bookheimer Lab, completing her thesis on “Imaging Genetics of Frontostriatal Function in Children with Autism Spectrum Disorders” using funding from a Neurogenetics Training Grant.

Add Comment